Merck, J&J Strike Deal In Arthritis Drugs Dispute
Merck & Co. Inc. said Friday it will pay Johnson & Johnson $500 million to end a dispute over rights to two arthritis drugs resulting from Merck's merger with Schering-Plough Corp.,...To view the full article, register now.
Already a subscriber? Click here to view full article